Abstract
BB5-G1, a monoclonal antibody specific for human parathyroid cell membrane antigen was conjugated with two new ligands, BrMe2HBED and BrφHBED and radiolabeled with 111In. We have compared the biodistribution of 111In-labeled BBS using the new ligands to conventionally labeled (125I-labeled and 111In-DTPA-labeled) BBS in a nude mouse model. Both 111In-BrMe2HBED-BB5 and 111In-BrφHBED-BB5 attained high parathyroid-to-blood and parathyroid-to-muscle ratios by 72-96 h. 111In-BrφHBED-BB5 showed lower %ID/g than 111In-BrMe2HBED-BB5 in the clearance organs, the liver and kidney; renal activity had cleared significantly by 120 h. This work suggests that 111In-BrφHBED-BB5 offers improved in vivo behavior and may be useful as a radiopharmaceutical for localizing parathyroid tissue.
Original language | English |
---|---|
Pages (from-to) | 477-481 |
Number of pages | 5 |
Journal | International Journal of Radiation Applications and Instrumentation. |
Volume | 18 |
Issue number | 5 |
DOIs | |
State | Published - 1991 |